Surgery Partners (NASDAQ:SGRY) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Wednesday.
SGRY has been the subject of a number of other research reports. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Saturday, January 13th. ValuEngine cut Surgery Partners from a “hold” rating to a “sell” rating in a research report on Sunday, December 31st. Bank of America cut Surgery Partners from a “buy” rating to a “neutral” rating and set a $19.00 target price for the company. in a research report on Wednesday, November 1st. Benchmark set a $19.00 target price on Surgery Partners and gave the stock a “buy” rating in a research report on Tuesday, January 30th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and set a $18.00 target price on shares of Surgery Partners in a research report on Sunday, November 12th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. Surgery Partners has an average rating of “Hold” and an average price target of $17.86.
Surgery Partners (SGRY) opened at $16.05 on Wednesday. Surgery Partners has a twelve month low of $7.10 and a twelve month high of $24.05. The company has a market capitalization of $794.94, a P/E ratio of -34.89 and a beta of 2.47. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56.
Surgery Partners announced that its Board of Directors has initiated a share repurchase program on Friday, December 15th that authorizes the company to buyback $50.00 million in shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.
A number of institutional investors have recently made changes to their positions in SGRY. We Are One Seven LLC bought a new stake in shares of Surgery Partners in the fourth quarter valued at approximately $138,000. Clearline Capital LP bought a new stake in shares of Surgery Partners in the fourth quarter valued at approximately $385,000. TIAA CREF Investment Management LLC boosted its position in shares of Surgery Partners by 38.3% in the fourth quarter. TIAA CREF Investment Management LLC now owns 69,701 shares of the company’s stock valued at $843,000 after acquiring an additional 19,290 shares during the period. Teachers Advisors LLC boosted its position in shares of Surgery Partners by 51.5% in the fourth quarter. Teachers Advisors LLC now owns 53,763 shares of the company’s stock valued at $651,000 after acquiring an additional 18,280 shares during the period. Finally, York Capital Management Global Advisors LLC bought a new stake in shares of Surgery Partners in the fourth quarter valued at approximately $2,281,000. 98.82% of the stock is owned by hedge funds and other institutional investors.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.